ArticleInternational immunopharmacology2022
The JAK inhibitor ruxolitinib abrogates immune hepatitis instigated by concanavalin A in mice.
Mohamed E Shaker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it